8 Recruiting Merkel Cell Carcinoma Phase 2 Clinical Trials
Active phase 2 studies for merkel cell carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Merkel Cell Carcinoma studiesPhase 2 Studies for Merkel Cell Carcinoma
🔵 Active, Not Recruiting Phase2
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
📍 H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
📍 Medical Dermatology Specialists — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 / Phase2
ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1
📍 University of Wisconsin-Carbone Cancer Center — Madison, Wisconsin
View Study & Checklist ➔ 🟢 Recruiting Phase2
Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2
Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma
📍 Penn Medicine — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase2
Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
📍 University of Iowa Hospitals and Clinics — Iowa City, Iowa
View Study & Checklist ➔